Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.

by Shanli Zhu, Jun Chen, Yirong Xiong, Saidu Kamara, Meiping Gu, Wanlin Tang, Shao Chen, Haiyan Dong, Xiangyang Xue, Zhi-Ming Zheng, Lifang Zhang
Published 2020-01-01

Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells

by Jinshun Zhu, Saidu Kamara, Danwei Cen, Wanlin Tang, Meiping Gu, Xingyuan Ci, Jun Chen, Lude Wang, Shanli Zhu, Pengfei Jiang, Shao Chen, Xiangyang Xue, Lifang Zhang
Published 2020-06-01